ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
-0,05%
Bitcoin
66.192,01
0,00%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. European Biotech Acquisition Corporation (EBAC)

  7. European Biotech Acquisition Corporation (EBAC) News

EBAC

European Biotech Acquisi... (EBAC)

European Biotech Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EBAC
DatumZeitQuelleÜberschriftSymbolFirma
13/03/202321h10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:EBACEuropean Biotech Acquisition Corporation
28/02/202322h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
28/02/202312h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
21/02/202323h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
14/02/202322h14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EBACEuropean Biotech Acquisition Corporation
14/02/202317h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EBACEuropean Biotech Acquisition Corporation
13/02/202322h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EBACEuropean Biotech Acquisition Corporation
06/02/202322h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EBACEuropean Biotech Acquisition Corporation
03/02/202323h11Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:EBACEuropean Biotech Acquisition Corporation
30/01/202314h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
14/12/202215h17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EBACEuropean Biotech Acquisition Corporation
14/11/202218h43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
17/10/202215h52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
15/08/202223h39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
16/05/202220h30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
31/03/202223h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
14/02/202212h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EBACEuropean Biotech Acquisition Corporation
27/01/202222h36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EBACEuropean Biotech Acquisition Corporation
23/11/202112h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
23/11/202112h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
15/11/202123h02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
18/08/202122h41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
22/06/202123h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
04/06/202122h40Business WireEuropean Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly ReportNASDAQ:EBACEuropean Biotech Acquisition Corporation
04/06/202122h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACEuropean Biotech Acquisition Corporation
17/05/202122h08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EBACEuropean Biotech Acquisition Corporation
14/05/202117h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EBACEuropean Biotech Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:EBAC

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
TG
MBG
MercedesBenz
TG
TUI1
Tui
FX
EURJPY
Euro vs Yen
TG
BAS
BASF
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
TG
CBK
Commerzbank
COIN
SOLUSD
Solana
TG
DBK
Deutsche Bank
CCOM
SILVER
SILVER
NYSE
NKE
Nike
TG
D7G
Nel ASA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten